Multidrug resistance (MDR) in
tumor cells is a significant obstacle for successful
cancer chemotherapy. Overexpression of
drug efflux transporters such as
P-glycoprotein (P-gp) is a key factor contributing to the development of
tumor drug resistance.
Verapamil (VRP), a P-gp inhibitor, has been reported to be able to reverse completely the resistance caused by P-gp. For optimal synergy, the
drug and inhibitor combination may need to be temporally colocalized in the
tumor cells. Herein, we investigated the effectiveness of simultaneous and targeted delivery of anticancer
drug,
paclitaxel (PTX), along with VRP, using DOMC-FA
micelles to overcome
tumor drug resistance. The floate-functionalized dual agent loaded
micelles resulted in the similar cytotoxicity to PTX-loaded
micelles/free VRP combination and co-administration of two single-agent loaded
micelles, which was higher than that of PTX-loaded
micelles. Enhanced therapeutic efficacy of dual agent
micelles could be ascribe to increased accumulation of PTX in
drug-resistant
tumor cells. We suggest that the synergistic effect of
folate receptor-mediated internalization and VRP-mediated overcoming MDR could be beneficial in treatment of MDR solid
tumors by targeting delivery of micellar PTX into
tumor cells. As a result, the difunctional
micelle systems is a very promising approach to overcome
tumor drug resistance.